Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Inflammatory Markers in Predicting Disease Recurrency and Cognitive Performance in Women With High Risk and Locally Advanced Breast Cancer

NCT00756132 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT00756132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00756132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Inflammatory Markers in Predicting Disease Recurrency and Cognitive Performance in Women With High Risk and Locally Advanced Breast Cancer
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Completed
Start date
August 31, 2008
Completion date
September 30, 2017
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, locally advanced breast cancer